Touloumi Giota, Karakosta Argiro, Sypsa Vana, Petraki Ioanna, Anagnostou Olga, Terzidis Agis, Voudouri Niki Maria, Gavana Magda, Vantarakis Apostolos, Rachiotis George, Kantzanou Maria, Rosenberg Theofilos, Papatheodoridis George, Hatzakis Angelos
Department of Hygiene, Epidemiology, and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
International Medicine-Health Crisis Management, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
JMIR Res Protoc. 2020 Jan 31;9(1):e13578. doi: 10.2196/13578.
Although infectious diseases are globally on the decline, they remain a major global public health problem. Among them, the hepatitis B virus (HBV) or hepatitis C virus (HCV) and HIV infection are of primary interest. Valid prevalence data on these infections are sparse in Greece, especially for vulnerable populations.
This study aimed to present the design and methods of Hprolipsis, an integrated viral hepatitis and HIV screening program administered to adults (≥18 years) from the general, Greek Roma, and migrant populations. Its aims were to estimate the prevalence of HBV, HCV, and HIV; assess infectious disease knowledge level; design, implement, and assess population-specific awareness actions; and offer individual counseling and referral when indicated and HBV vaccination to susceptible Roma and migrants.
Multistage, stratified, random sampling based on the 2011 Census was applied to select the general population sample, and nonprobability multistage quota sampling was used for Roma and migrant sample selection. Trained personnel made home (general population) or community (Roma and migrants) visits. Collected blood samples were tested for Hepatitis B surface Antigen, Hepatitis B core Antibody, Hepatitis B surface Antibody, Hepatitis C Antibody, and HIV 1,2 Antibody. The surveys were conducted during May 2013 and June 2016. To estimate an HCV prevalence of 1.5% with 0.3 precision, the required general population sample size was estimated to be 6000. As migrants constitute 10% of the whole Greek population, the migrant sample size was set to 600. A feasible sample size of 500 Greek Roma was set.
In total, 6006 individuals from the general population (response rate 72%), 534 Greek Roma, and 612 migrants were recruited. Blood test results are available for 4245 individuals from the general population, 523 Roma, and 537 migrants.
Hprolipsis is the first nationwide survey on HBV, HCV, and HIV. Its results will enhance our understanding of the health needs and disease burden of these diseases in the 3 studied populations. Its implementation provided useful recommendations for future studies, particularly in vulnerable populations.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/13578.
尽管传染病在全球范围内呈下降趋势,但它们仍然是一个主要的全球公共卫生问题。其中,乙型肝炎病毒(HBV)或丙型肝炎病毒(HCV)以及艾滋病毒感染是主要关注点。在希腊,关于这些感染的有效流行率数据稀少,尤其是针对弱势群体。
本研究旨在介绍Hprolipsis的设计和方法,这是一项针对希腊普通人群、罗姆人群体和移民群体中成年人(≥18岁)的病毒性肝炎和艾滋病毒综合筛查项目。其目的是估计HBV、HCV和HIV的流行率;评估传染病知识水平;设计、实施和评估针对特定人群的宣传活动;并在有指征时提供个人咨询和转诊服务,以及为易感的罗姆人和移民提供乙肝疫苗接种。
基于2011年人口普查采用多阶段、分层随机抽样来选择普通人群样本,对罗姆人和移民样本选择采用非概率多阶段配额抽样。训练有素的人员进行上门(普通人群)或社区(罗姆人和移民)访问。采集的血样检测乙肝表面抗原、乙肝核心抗体、乙肝表面抗体、丙肝抗体以及HIV 1、2抗体。调查于2013年5月至2016年6月期间进行。为了以0.3的精度估计丙肝流行率为1.5%,估计所需的普通人群样本量为6000。由于移民占希腊总人口的10%,移民样本量设定为600。设定了500名希腊罗姆人的可行样本量。
总共招募了6006名普通人群个体(应答率72%)、534名希腊罗姆人和612名移民。普通人群中有4245名个体、罗姆人中有523名个体和移民中有537名个体的血液检测结果可用。
Hprolipsis是首次针对HBV、HCV和HIV的全国性调查。其结果将增进我们对这三种研究人群中这些疾病的健康需求和疾病负担的理解。其实施为未来研究,特别是针对弱势群体的研究提供了有用的建议。
国际注册报告识别码(IRRID):DERR1-10.2196/13578